about
Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthaseAkt: A Therapeutic Target in Hepatic Ischemia-Reperfusion Injury.Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.Effect of Ixeris dentata Nakai Extract on Nitric Oxide Production and Prostaglandin E2 Generation in LPS-stimulated RAW264.7 CellsAdditive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage.Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis.Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy.Glutamine prevents oxidative stress in a model of portal hypertensionDuctular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats.EPOR2/βcR2-independendent effects of low-dose epoetin-α in porcine liver transplantation.The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.Anti-hyperlipidemic effect of rice bran polysaccharide and its potential mechanism in high-fat diet mice.Hepatic stellate cell autophagy in acute liver injury: A novel role for nitric oxide?The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.S-Allyl cysteine alleviates inflammation by modulating the expression of NF-κB during chromium (VI)-induced hepatotoxicity in rats.Downregulation of L-arginine metabolism in dendritic cells induces tolerance to exogenous antigen.Effects of ferric citrate supplementation on advanced glycation end products in a rat model of streptozotocin/nicotinamide-induced diabetes.A novel liver-targeted nitric oxide donor UDCA-Thr-NO protects against cirrhosis and portal hypertension.Deletion of caveolin-1 attenuates LPS/GalN-induced acute liver injury in miceA Synthetic Peptide AWRK6 Alleviates Lipopolysaccharide-Induced Liver Injury
P2860
Q26771779-A5930D67-5B70-4019-BAE9-3DD7B1D4F7A9Q30248771-19330556-CCEE-4C8D-9C46-2E0FD7FB3A28Q36413812-6CABEEF3-F1FE-4E08-ACB2-4B7A73879F7EQ36427750-28190A79-1FCC-4AC6-9A96-D2D2A7C6C348Q36846905-66406119-7CF2-46AB-9606-5B0F51CFEEBAQ37300472-57E62DB3-3CD2-4E50-B095-2448105E1011Q38616699-228F39E0-7849-4239-B111-C443C4EDF48CQ39379029-B057FFEF-9860-4889-B33A-39B9E79651EEQ40277667-5C3DDE6E-0408-444F-9421-C68854DFDFCDQ40976036-DC10BAD0-01BD-4116-BDB8-559169A2DF6CQ45857384-AB1D6A82-5F59-46BC-B1A8-A67FAF11B47BQ47093489-8D38FA27-B147-47C7-A719-0A1A3F5AFC20Q47258601-D77F795A-6E57-4282-9300-237618EB8E37Q47720428-C870F257-8F54-49D4-A29C-D62C126CA2D8Q48135929-2C91CBC2-D7E6-4C51-9AF4-8CD81C91BBA6Q48331734-E8F1CB0B-4E2C-4D04-93F5-AEA5EA7CA08FQ49500142-B6C13050-B9EC-43F9-9342-3E4A7784CA55Q50335929-133A9F7D-36A3-4577-975B-978547CB6A84Q51318083-268EEA30-31BF-4202-876D-38EE9AEBEB04Q52670963-5685BA75-26FF-43FE-8ADA-5F006916821FQ58716583-C39C9152-0CFA-47C9-9776-6F112440646CQ58758206-5A40482D-84A1-4569-8904-8897FE27DA78
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nitric oxide in liver diseases.
@ast
Nitric oxide in liver diseases.
@en
type
label
Nitric oxide in liver diseases.
@ast
Nitric oxide in liver diseases.
@en
prefLabel
Nitric oxide in liver diseases.
@ast
Nitric oxide in liver diseases.
@en
P2860
P1476
Nitric oxide in liver diseases.
@en
P2093
Moon Young Kim
Yasuko Iwakiri
P2860
P304
P356
10.1016/J.TIPS.2015.05.001
P577
2015-05-28T00:00:00Z